Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,596 | 245 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $892.34 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $865.79 | 69 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $746.62 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $460.58 | 20 | $0 (2024) |
| PFIZER INC. | $263.77 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $193.61 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $139.54 | 9 | $0 (2023) |
| Boston Scientific Corporation | $121.64 | 1 | $0 (2023) |
| Amgen Inc. | $108.41 | 7 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $103.41 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,221 | 64 | Boehringer Ingelheim Pharmaceuticals, Inc. ($280.81) |
| 2023 | $1,344 | 76 | Novartis Pharmaceuticals Corporation ($227.71) |
| 2022 | $1,110 | 60 | AstraZeneca Pharmaceuticals LP ($260.52) |
| 2021 | $919.95 | 45 | AstraZeneca Pharmaceuticals LP ($338.05) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardiology | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 445 | 985 | $66,747 | $27,211 |
| 2022 | 4 | 575 | 909 | $91,161 | $36,144 |
| 2021 | 5 | 581 | 679 | $95,962 | $38,723 |
| 2020 | 7 | 494 | 595 | $72,136 | $22,704 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 166 | 240 | $35,040 | $13,699 | 39.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2023 | 191 | 656 | $21,668 | $9,601 | 44.3% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 25 | 26 | $8,320 | $3,141 | 37.8% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Facility | 2023 | 18 | 18 | $818.82 | $405.36 | 49.5% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Facility | 2023 | 45 | 45 | $900.00 | $365.40 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 355 | 448 | $65,408 | $26,290 | 40.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2022 | 93 | 321 | $10,603 | $4,980 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 116 | 129 | $12,642 | $3,855 | 30.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 11 | 11 | $2,508 | $1,018 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 308 | 383 | $55,918 | $22,952 | 41.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 175 | 197 | $19,306 | $7,565 | 39.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2021 | 49 | 50 | $16,000 | $6,171 | 38.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2021 | 16 | 16 | $3,648 | $1,485 | 40.7% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Facility | 2021 | 33 | 33 | $1,090 | $549.44 | 50.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 306 | 399 | $39,102 | $12,007 | 30.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2020 | 40 | 40 | $12,800 | $4,080 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 73 | 75 | $10,950 | $3,377 | 30.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2020 | 29 | 29 | $6,612 | $2,308 | 34.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 22 | 26 | $1,534 | $414.18 | 27.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 12 | 12 | $608.00 | $304.41 | 50.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 12 | 14 | $530.00 | $212.28 | 40.1% |
About Amy Wall
Amy Wall is a Family healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1346751195.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Wall has received a total of $4,596 in payments from pharmaceutical and medical device companies, with $1,221 received in 2024. These payments were reported across 245 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,596).
As a Medicare-enrolled provider, Wall has provided services to 2,095 Medicare beneficiaries, totaling 3,168 services with total Medicare billing of $124,781. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Jackson, MS
- Active Since 10/19/2017
- Last Updated 03/12/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346751195
Products in Payments
- JARDIANCE (Drug) $892.34
- LEQVIO (Drug) $553.64
- VERQUVO (Drug) $431.42
- FARXIGA (Drug) $339.67
- ELIQUIS (Drug) $334.53
- ENTRESTO (Drug) $312.15
- BRILINTA (Drug) $200.29
- XARELTO (Drug) $193.61
- WATCHMAN (Device) $121.64
- LOKELMA (Drug) $114.06
- Repatha (Biological) $108.41
- Barostim Neo System (Device) $87.89
- FUROSCIX (Drug) $81.48
- OPTIMIZER (Device) $80.83
- GALLANT (Device) $75.63
- Inpefa (Drug) $69.58
- ONPATTRO (Drug) $65.83
- VYNDAQEL (Drug) $36.66
- FFRct (Device) $34.88
- Arcalyst (Drug) $32.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Jackson
Gina Burge, Np, NP
Family — Payments: $182,303
Mrs. Dana Delaski, Np-C, NP-C
Family — Payments: $145,155
Anahita Anderson, Fnp, FNP
Family — Payments: $51,628
Leondrea Stewart Collins, Fnp-C, FNP-C
Family — Payments: $14,319
Anna Walley, Fnp, FNP
Family — Payments: $13,785
Teresa Spencer, Cfnp, CFNP
Family — Payments: $12,519